Clinical Performance Evaluation of the NeuMoDx™ FluA/FluB/RSV/Severe Acute Respiratory Syndrome-CoV-2 Assay
Sponsored by QIAGEN Gaithersburg, Inc
About this trial
Last updated 3 years ago
Study ID
Status
Type
Placebo
Accepting
Not accepting
Trial Timing
Ended 3 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Fresh specimens shall be collected from all comers across the study duration
- Collected from individuals of any age presenting with influenza-like illness (ILI)
- Nasopharyngeal (NP) swab specimen obtained using a flexible mini-tip flocked swab and collected into 3 mL Copan® Universal Transport Media (UTM) [Cat. No.305c] or Beckton Dickinson (BD™) Universal Viral Transport (UVT) [Cat. No. 220531]
- Minimum volume for residual specimen approximately 2 mL
- Fresh specimens to be tested within 3 days of collection.
- Fresh specimens to be stored under the recommended stability conditions (2-8°C).
Exclusion Criteria
- Required information unable to be obtained from associated medical chart.
- Specimens not fitting criteria outlined above.